Bromocriptine Mesylate and Moxetumomab Pasudotox-tdfk
Determining the interaction of Bromocriptine Mesylate and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Moxetumomab pasudotox-tdfk Intravenous
- Bromocriptine Mesylate-Moxifloxacin
- Bromocriptine Mesylate-Moxifloxacin (Systemic)
- Bromocriptine Mesylate-Moxifloxacin Hydrochloride
- Bromocriptine Mesylate-Moxifloxacin Injection
- Bromocriptine Mesylate-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Brompheniramine
- Moxetumomab Pasudotox-tdfk-Brompheniramine and codeine
- Moxetumomab Pasudotox-tdfk-Brompheniramine and phenylephrine
- Moxetumomab Pasudotox-tdfk-Brompheniramine and Phenylephrine Chewable Tablets
- Moxetumomab Pasudotox-tdfk-Brompheniramine and Phenylephrine Liquid
- Moxetumomab Pasudotox-tdfk-Brompheniramine and Phenylephrine Suspension